UCL Institute of Ophthalmology, London EC1V 9EL, United Kingdom; Moorfields Eye Hospital, London EC1V 2PD, United Kingdom; Eye Hospital, University Medical Centre, Ljubljana SL 1000, Slovenia.
UCL Institute of Ophthalmology, London EC1V 9EL, United Kingdom; Moorfields Eye Hospital, London EC1V 2PD, United Kingdom.
Exp Eye Res. 2014 May;122:9-12. doi: 10.1016/j.exer.2014.02.018. Epub 2014 Mar 4.
Recessive variants in the USH2A gene are an important cause of both Usher syndrome and nonsyndromic retinitis pigmentosa. A single base-pair deletion in exon 13 (c.2299delG, p.Glu767Serfs*21) is considered the most frequent mutation of USH2A. It is predicted to generate a premature termination codon and is presumed to lead to nonsense mediated decay. However the effect of this variant on RNA has not been formally investigated. It is not uncommon for exonic sequence alterations to cause aberrant splicing and the aim of the present report is to evaluate the effect of c.2299delG on USH2A transcripts. Nasal cells represent the simplest available tissue to study splicing defects in USH2A. Nasal brushing, RNA extraction from nasal epithelial cells and reverse transcription PCR were performed in five Usher syndrome patients who were homozygous for c.2299delG, two unaffected c.2299delG heterozygotes and seven control individuals. Primers to amplify between exons 12 and 15 and exons 10 and 14 were utilised. Significant variability was observed between different RT-PCR experiments. Importantly, in controls, PCR product of the expected size were amplified on all occasions (13/13 experiments); for patients this was true in only 4/14 experiments (Fisher exact test p = 0.0002). Bioinformatics tools predict the c.2299delG change to disrupt an exonic splicing enhancer and to create an exonic splicing silencer within exon 13. Here, we report an effect of the common c.2299delG mutation on splicing of exons 12 and 13 of USH2A. Future studies are expected to provide important insights into the contribution of this effect on the phenotype.
USH2A 基因中的隐性变异是导致 Usher 综合征和非综合征性视网膜色素变性的重要原因。第 13 外显子中的单个碱基对缺失(c.2299delG,p.Glu767Serfs*21)被认为是 USH2A 最常见的突变。据预测,该突变会产生一个过早终止密码子,并导致无意义介导的衰变。然而,该变体对 RNA 的影响尚未进行正式研究。外显子序列改变导致异常剪接并不罕见,本报告的目的是评估 c.2299delG 对 USH2A 转录本的影响。鼻细胞是研究 USH2A 剪接缺陷的最简单的可用组织。对 5 名纯合 c.2299delG 的 Usher 综合征患者、2 名无影响的 c.2299delG 杂合子和 7 名对照个体进行了鼻刷、鼻上皮细胞 RNA 提取和逆转录 PCR。利用扩增 12 号和 15 号外显子以及 10 号和 14 号外显子之间的引物进行实验。不同 RT-PCR 实验之间观察到显著的变异性。重要的是,在对照组中,所有情况下都扩增出预期大小的 PCR 产物(13/13 次实验);而在患者中,这种情况仅在 4/14 次实验中为真(Fisher 精确检验 p=0.0002)。生物信息学工具预测,c.2299delG 变化会破坏外显子剪接增强子,并在第 13 号外显子内产生外显子剪接沉默子。在这里,我们报告了常见的 c.2299delG 突变对 USH2A 的第 12 和 13 号外显子剪接的影响。未来的研究有望提供关于该影响对表型贡献的重要见解。